In a study by Zhang et al. [63] (2011), USP22 was found to be up-regulated in breast cancer patient samples and was associated with aggressive phenotypes and decreased levels of H2Bub1 compared with benign tumors. This evidence concerns the gene USP22 and breast cancer.